Actively Recruiting
Dexmedetomidine and Agitation After Nasal Surgery
Led by Fayoum University Hospital · Updated on 2025-03-10
50
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The main objective of study is to compare dexmedetomidine single bolus dose before extubation with continuous infusion as regards their efficacy in mitigating the incidence of emergence agitation in obese adults undergoing nasal surgery.
CONDITIONS
Official Title
Dexmedetomidine and Agitation After Nasal Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- American Society of Anesthesiologist (ASA) I or II
- Adults with body mass index (BMI) < 30 Kg/m
- Underwent elective nasal surgery.
You will not qualify if you...
- Significant comorbidity like hepatic, renal, or cardiac disease
- Auditory impairment
- Cognitive dysfunction
- Substance abuse
- Allergy to the studied medicines
- Planned intensive care admission after the surgery.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Fayoum University Hospital
Al Fayyum, Faiyum Governorate, Egypt, 63514
Actively Recruiting
Research Team
Y
Yasser S Mostafa, MD
CONTACT
M
Mohamed A Shawky, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here